| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer | Senior Vice President, R&D | Senior Vice President, R&D
1 company
Rote William E. serves as a Chief Research Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 51 sells. Those positions are worth an estimated $7.4M at current prices.
Historically, Rote William E.'s trades have earned a middling insider score of 58/100 across 20 rated trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -15.7%.
The biggest single holding is TVTX (~$7.4M) as Chief Research Officer. The recent filings there lean toward selling, a net 164,628 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 15, 2019 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,625 | $17.77 | $28,876.26 | -4.2% | |
| Feb 19, 2019 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,500 | $21.48 | $53,700.00 | -8.0% | |
| Feb 12, 2019 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,985 | $21.44 | $42,558.34 | -5.7% | |
| Nov 15, 2018 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 5,000 | $24.03 | $120,129.55 | -6.1% | |
| Feb 14, 2018 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,034 | $21.50 | $22,232.03 | -8.5% |